Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi Lepri

Showing results (31-40 of 244) with videos related to

Pageof 25
Sort By:
AIDS (London, England)|March 2, 2002
Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiationCarlo Federico Perno, Alessandro Cozzi-Lepri, Claudia Balotta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining conditionAntonella Cingolani, Alessandro Cozzi Lepri, Antonella Castagna, et al.
Antiviral Therapy|August 6, 2011
Predictors of having a resistance test following confirmed virological failure of combination antiretroviral therapy: data from EuroSIDAZoe V Fox, Alessandro Cozzi-Lepri, Antonella D'Arminio Monforte, et al.
AIDS (London, England)|February 23, 2007
Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?Paola Cicconi, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
AIDS (London, England)|August 10, 2012
Polyclonal serum-free light chains elevation in HIV-infected patientsMichele Bibas, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
AIDS (London, England)|October 30, 2009
Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasetsLambert Assoumou, Alessandro Cozzi-Lepri, Françoise Brun-Vézinet, et al.
Plos One|January 28, 2017
Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or DeathMaria Casadellà, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
Journal of the International AIDS Society|November 14, 2014
Increased incidence of sexually transmitted diseases in the recent years: data from the ICONA cohortAntonella Cingolani, Stefano Zona, Enrico Girardi, et al.
Journal of the International AIDS Society|November 15, 2014
An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in ItalyAlessandro Cozzi-Lepri, Andrea Antinori, Stefano Bonora, et al.
Antiviral Therapy|November 13, 2004
The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug?Massimo Puoti, Alessandro Cozzi-Lepri, Fausto Ancarani, et al.
Pageof 25

Showing results (31-40 of 244) with videos related to

Sort By:
Pageof 25
AIDS (London, England)|March 2, 2002
Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiationCarlo Federico Perno, Alessandro Cozzi-Lepri, Claudia Balotta, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 14, 2011
Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining conditionAntonella Cingolani, Alessandro Cozzi Lepri, Antonella Castagna, et al.
Antiviral Therapy|August 6, 2011
Predictors of having a resistance test following confirmed virological failure of combination antiretroviral therapy: data from EuroSIDAZoe V Fox, Alessandro Cozzi-Lepri, Antonella D'Arminio Monforte, et al.
AIDS (London, England)|February 23, 2007
Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?Paola Cicconi, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
AIDS (London, England)|August 10, 2012
Polyclonal serum-free light chains elevation in HIV-infected patientsMichele Bibas, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
AIDS (London, England)|October 30, 2009
Development of a didanosine genotypic resistance interpretation system based on large derivation and validation datasetsLambert Assoumou, Alessandro Cozzi-Lepri, Françoise Brun-Vézinet, et al.
Plos One|January 28, 2017
Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or DeathMaria Casadellà, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
Journal of the International AIDS Society|November 14, 2014
Increased incidence of sexually transmitted diseases in the recent years: data from the ICONA cohortAntonella Cingolani, Stefano Zona, Enrico Girardi, et al.
Journal of the International AIDS Society|November 15, 2014
An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in ItalyAlessandro Cozzi-Lepri, Andrea Antinori, Stefano Bonora, et al.
Antiviral Therapy|November 13, 2004
The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug?Massimo Puoti, Alessandro Cozzi-Lepri, Fausto Ancarani, et al.
Pageof 25